1. Market Research
  2. > All Companies
  3. > Apotex, Inc. - Strategic SWOT Analysis Review

Apotex, Inc. - Strategic SWOT Analysis Review

  • February 2015
  • -
  • Global Data
  • -
  • 31 pages

Apotex, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Apotex, Inc. (Apotex) is a pharmaceutical company. It carries out the production and marketing of a wide range of generic pharmaceuticals. It also undertakes the research, development, manufacturing and distribution of non-prescription and private label medicines, fine chemicals and disposable plastics for medicinal use. The company focuses on providing an array of affordable medicines to patients, healthcare providers, payers and governments worldwide. The company operates through affiliates in Canada, Mexico, the US, Belgium, Argentina, Czech Republic, Italy, the Netherlands, Poland, Spain, Australia, India, New Zealand, Saudi Arabia and Turkey. It also has manufacturing and distribution facilities worldwide. Apotex is headquartered in Toronto, Ontario, Canada.

Apotex, Inc. Key Recent Developments

Aug 22, 2013: Apotex Inc. invests in patient care reinvented: pledges $10 Million in support of the New Humber River Hospital
May 25, 2013: Apotex And Pro Doc Provide Safety Information On Apo-Clindamycin, Clindamycine-150 And Clindamycine-300
Mar 13, 2013: FTC Files Amicus Brief On Improper Use Of Restricted Drug Distribution Programs
Feb 21, 2013: Apotex Receives FDA Warning Letter

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Table Of Contents

Apotex, Inc. - Strategic SWOT Analysis Review
Table of Contents
Section 1 - About the Company 6
Apotex, Inc. - Key Facts 6
Apotex, Inc. - Key Employees 7
Apotex, Inc. - Key Employee Biographies 8
Apotex, Inc. - Major Products and Services 9
Apotex, Inc. - History 11
Apotex, Inc. - Company Statement 14
Apotex, Inc. - Locations And Subsidiaries 15
Head Office 15
Other Locations and Subsidiaries 15
Section 2 - Company Analysis 17
Apotex, Inc. - Business Description 17
Apotex, Inc. - SWOT Analysis 18
SWOT Analysis - Overview 18
Apotex, Inc. - Strengths 18
Strength - Dominant Market Position 18
Strength - Strong In-house Research Capabilities 18
Strength - Global Network 18
Apotex, Inc. - Weaknesses 19
Weakness - Product Recalls 19
Weakness - Locked-up Enterprise Value 19
Apotex, Inc. - Opportunities 20
Opportunity - Strategic Initiatives 20
Opportunity - Resuming Shipping to the US 20
Apotex, Inc. - Threats 21
Threat - Stringent Government Regulations 21
Threat - Uncertain RandD Outcomes 21
Threat - Highly Competitive Generic Drug Market 21
Apotex, Inc. - Key Competitors 22
Section 3 - Company's Lifesciences Financial Deals and Alliances 23
Apotex, Inc., Pharmaceuticals and Healthcare, Deals By Year, 2009 to YTD 2015 23
Apotex, Inc., Pharmaceuticals and Healthcare, Deals By Type, 2009 to YTD 2015 24
Apotex, Inc., Recent Deals Summary 25
Section 4 - Company's Recent Developments 26
Dec 12, 2014: Panacea Biotec Announces Strategic Alliance With Apotex 26
Dec 03, 2014: Meda and Cipla sue Apotex to enforce Dymista® patents 27
Sep 24, 2014: Information Update - Health Canada requests quarantine of products for Canadian market from Apotex facility in Bangalore, India 28
Aug 26, 2014: Apotex Announces Dr. Jeremy B. Desai as President and CEO 29
Aug 26, 2014: Appointment Announcement - Dr. Jeremy B. Desai, President and CEO, Apotex 30
Section 5 - Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Apotex, Inc., Key Facts 6
Apotex, Inc., Key Employees 7
Apotex, Inc., Key Employee Biographies 8
Apotex, Inc., Major Products and Services 9
Apotex, Inc., History 11
Apotex, Inc., Other Locations 15
Apotex, Inc., Subsidiaries 15
Apotex, Inc., Key Competitors 22
Apotex, Inc., Pharmaceuticals and Healthcare, Deals By Year, 2009 to YTD 2015 23
Apotex, Inc., Pharmaceuticals and Healthcare, Deals By Type, 2009 to YTD 2015 24
Apotex, Inc., Recent Deals Summary 25

List of Figures
Apotex, Inc., Pharmaceuticals and Healthcare, Deals By Year, 2009 to YTD 2015 23
Apotex, Inc., Pharmaceuticals and Healthcare, Deals by Type, 2009 to YTD 2015 24

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.